Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background: Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus, are increasingly common among patients with cystic fibrosis and chronic bronchiectatic lung diseases. Treatment is challenging due to intrinsic antibiotic resistance. Bacteriophage therapy represents a potentially novel approach. Relatively few active lytic phages are available and there is great variation in phage susceptibilities among M. abscessus isolates, requiring personalized phage identification. Methods: Mycobacterium isolates from 200 culture-positive patients with symptomatic disease were screened for phage susceptibilities. One or more lytic phages were identified for 55 isolates. Phages were administered intravenously, by aerosolization, or both to 20 patients on a compassionate use basis and patients were monitored for adverse reactions, clinical and microbiologic responses, the emergence of phage resistance, and phage neutralization in serum, sputum, or bronchoalveolar lavage fluid. Results: No adverse reactions attributed to therapy were seen in any patient regardless of the pathogen, phages administered, or the route of delivery. Favorable clinical or microbiological responses were observed in 11 patients. Neutralizing antibodies were identified in serum after initiation of phage delivery intravenously in 8 patients, potentially contributing to lack of treatment response in 4 cases, but were not consistently associated with unfavorable responses in others. Eleven patients were treated with only a single phage, and no phage resistance was observed in any of these. Conclusions: Phage treatment of Mycobacterium infections is challenging due to the limited repertoire of therapeutically useful phages, but favorable clinical outcomes in patients lacking any other treatment options support continued development of adjunctive phage therapy for some mycobacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“successfully used to treat chronic, drug-resistant infections of M. abscessus (177–179)”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [178]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Phages have also been explored as diagnostic tools, and successfully used to treat chronic, drug-resistant infections of M. abscessus (177–179).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Self-citationSchooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Self-citationJault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1125 · Cited by 786
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Phage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Self-citationSarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Aslam, S., Lampley, E., Wooten, D., Karris, M., Benson, C., Strathdee, S., & Schooley, R. T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa389 · Cited by 342
Self-citationNick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251 · cited 1×
“chelonae skin infection (patient 16); details of patients 15 and 16 were recently reported [22, 23].”
BackgroundSelf-citation
Research works printed but not linked: 1
- Guerrero-Bustamante, 2021, Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains, mBio, 12, e00973-21, 10.1128/mbio.00973-21 · DOI · Paper page
Cited by
Items 301–400 of 416
The enemy of my enemy is my friend
Voss, S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci183885 · Cited by 1
On the prospective use of bacteriophages in the treatment of cystic fibrosis
Garshina, V. D., Zhdanova, P. A., Litvinova, E. Y., Eshmakov, G. S., & Budanova, E. V. (2023) · Infectious diseases News Opinions Training · doi:10.33029/2305-3496-2023-12-3-120-130 · Cited by 1
Baliraine, F. W., Mathews, K. E., Livingston, E. G., Martinez, C. A., Donnelly, O. L., Pledger, T. M., Feroz, T., Harbison, Z. J., Schlimme, S. G., Andrade, C., et al. (2023) · Microbiology Resource Announcements · doi:10.1128/mra.01010-23 · Cited by 1
Nontuberculous Mycobacteria Pulmonary Infection in Children with Cystic Fibrosis
Hussain, S. R., Said, A. M., & Starke, J. R. (2024) · Current Infectious Disease Reports · doi:10.1007/s11908-024-00846-8 · Cited by 1
1. The Challenge of Antimicrobial Resistance (AMR) as a Silent Pandemic
Tateda, K. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.1648 · Cited by 1
Middleton, Z., Alves, G., Bavuso, E., Bui, P.-A., Jandial, K., Kirchner, D., Kiskamp, T., Morgan, B., Osei, K., Paradkar, R., et al. (2024) · PubMed Central · doi:10.17912/micropub.biology.001478 · Cited by 1
Kerr, S. J. (2023) · Nottingham ePrints (University of Nottingham) · Cited by 1
Asbóth, A., Stirling, T., Méhi, O., Apjok, G., Klein-Sousa, V., Taylor, N. M. I., Mehdi, H. H., Papp, B., Ari, E. E., & Kintses, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.20.706991 · Cited by 1
Engineering a Minimal Pseudomonas aeruginosa Bacteriophage
Javorčík, P. N. (2023) · TSpace (University of Toronto) · Cited by 1
Winkler, A., Pivonka, A., Conry-Murray, A., Petruconis, C. R., Patterne, I., Bergman, B., Binder, E., Blackley, J., Brown, R., Commale, K., et al. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.00754-22
Complete Genome Sequences of Mycobacterium smegmatis Phages MelsMeow, Yorick, Virgeve, and Mikro
Frost, V. J., Fogle, J. E., Harris, R. N., Jewell, B., Mills, K. E., Morgan, J. E., Thompson, P. T., Umemoto, E., & Westover, K. M. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.00758-22
Complete Genome Sequence and Characteristics of Mycobacteriophage IkeLoa
Wheatley, H. R., Kushner, S. R., & Baliraine, F. N. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.00985-22
Complete Genome Sequences of Cluster F1 Mycobacteriophages Akhila and MilanaBonita
Ahsan, U., Ali, N., Akintunde, C. A., Ali, M. A., Bond, C., Canada, B., Choudhry, S., Cortez, D., Dennis, N., Gomez, T., et al. (2022) · Microbiology Resource Announcements · doi:10.1128/mra.01191-22
ACTUALIZACIÓN DEL MANEJO DE MICOBACTERIAS NO TUBERCULOSAS
Pablo Jorquera, P., & Ricardo Madrid, H. (2023) · Neumología Pediátrica · doi:10.51451/np.v18i1.530
Use of Bacteriophages in Lung Transplantation
Berastegui, C., López‐Meseguer, M., & Zapata‐Ortega, M. (2023) · Barcelona Respiratory Network · doi:10.23866/brnrev:2023-m0096
Environmental Opportunistic Nontuberculous Mycobacteria
Primm, T. P., Falkinham, J. O., & Honda, J. R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00106-x
Bass, S., Coates, D., Frasketi, N., James, S., Marella, V., Pulla, R., Stoecker, K., Tupurani, S., & Johnson, A. A. (2024) · Microbiology Resource Announcements · doi:10.1128/mra.01253-23
Hisert, K. B., & Nick, J. A. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202402-129ed
Self-citationBorisov, S. Y., & Guntupova, L. (2024) · doi:10.18093/978-5-6048754-6-9-2024-2-603-627
Complete genome sequence of Wildflower, an O cluster mycobacteriophage
Sungu, N. L., Machowski, E. E., Ealand, C. S., & Kana, B. D. (2024) · Microbiology Resource Announcements · doi:10.1128/mra.00908-24
Recent Advancements in mycobacterial diseases research
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5606-1
Diagnosis and Treatment of Mycobacterial Infections
Wang, L., Bi, L., Hu, X., & Zhang, Y. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005549
Complete genome sequences of mycobacteriophages Ashwin from cluster O and Chanagan from cluster A1
Machowski, E. E., Gordhan, K., Madhav, C., Ealand, C. S., & Kana, B. D. (2024) · Microbiology Resource Announcements · doi:10.1128/mra.01028-24
Reviving Phage Therapy: A Novel Approach to Treat Respiratory-Associated Infections
Nachimuthu, R., Juliet, R., Bershiyal, S., & Mitra, O. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_16
Three Cluster O mycobacteriophages isolated in Philadelphia, PA
DiGiacomo, A., Bowen, N., Nguyen, T., Borrello, S., Brooks, N., Bubeck, E., Buker, C., Charboneau, L., Corapi, A., Derstine, K., et al. (2024) · PubMed Central · doi:10.17912/micropub.biology.001375
Hazra, M., Dubey, R. C., & Hazra, S. (2024) · Science and Culture · doi:10.36094/sc.v89.2024.phage_therapy_the_ultimate_alternative_against.hazra.490
Complete genome sequences of mycobacteriophages JayJay and Rinkes
Liebenberg, D., Sungu, N. L., Machowski, E. E., Ealand, C. S., & Kana, B. D. (2025) · Microbiology Resource Announcements · doi:10.1128/mra.01199-24
Huang, J. H., Friedman‐Moraco, R., & Pouch, S. M. (2025) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001177
Comparative study on the virulence of mycobacteriophages
Rubino, I., Guerrero-Bustamante, C. A., Harrison, M., Co, S., Tetreau, I., Ordoubadi, M., Larsen, S. E., Coler, R. N., Vehring, R., Hatfull, G. F., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01920-24
Self-citationWang, C., Duan, A.-F., Pan, D.-M., Zhao, Y.-O., Yang, J., & Sun, Y.-C. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04214-x
Fang, L., Nafziger, E., Guo, M., & Saha, M. S. (2025) · ACS Omega · doi:10.1021/acsomega.5c02222
González-García, J. G., Cumplí-Gargallo, M. C., Domínguez‐Álvarez, M., & Hurley, P. J. (2025) · Barcelona Respiratory Network · doi:10.23866/brnrev:2025-m0142
Phage Therapy For People With Cystic Fibrosis Pseudomonas aeruginosa Lung Infection
Ng, R. N. Y. W. (2023) · UWA Profiles and Research Repository (University of Western Australia) · doi:10.26182/4x5f-2740
Wu, J., Yang, Y., Yu, J., Qiao, L., Zuo, W., & Zhang, B. (2023) · Figshare · doi:10.6084/m9.figshare.24655778
Leveraging Temperate Phages To Enhance Antibiotic Effectiveness
Fatima, R. (2025) · MacSphere (McMaster University) · doi:10.71548/13327
Engineering bacteriophage as multi-purpose tools against biofilm associated infections
Burton, N. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33935398
Borin, J. M. (2023) · eScholarship (California Digital Library)
Formulation, Purification, and Application of Phages to Combat Pseudomonas aeruginosa
Luong, T. (2024) · eScholarship (California Digital Library)
Madhav, C., Gordhan, K., Sungu, N. L., Machowski, E. E., Ealand, C. S., Gordhan, B. G., & Kana, B. D. (2025) · PHAGE · doi:10.1177/26416549251371574
AIE-Bacteriophage Conjugated Bioprobes for Bacterial Detection
Zhang, J., & He, X. (2025) · Springer eBooks · doi:10.1007/978-981-97-1574-9_126-1
Isolation and Characterization of the subcluster L2 Mycobacteriophage Underpass and its lysogen
Toth, K. R., Rogers, A. R., Wenzel, E. R., Ponnwitz, F., Galdo, M.-L., Lacour, P. M., Cruz, J. A. T., Parikh, M., Hennessy, I. B. B., Duval, N. K., et al. (2025) · PubMed Central · doi:10.17912/micropub.biology.001915
Borsynbayeva, A., Turgenbayev, K., Sarsenova, G., Tlegenova, Z., & Berdiakhmetkyzy, S. (2025) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2025.860.872
Fibrosis Quística del Adulto : Comorbilidades de una enfermedad crónica y sus factores pronósticos
Montiel, A. F. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Burke, A., Jahnke, N., Smith, S. J., Smyth, A. R., Stewart, I. D., Tillman, L., & Nick, J. A. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.12.014
Self-citationSousa, M. C. R. R. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Охасовна, А. Р., Rubalsky, O. V., Lazko, M. V., Yasenyavskaya, A. L., & Rubalskaia, T. S. (2026) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-11-12-63-74
Complete Genome Sequence of the Subcluster C1 Mycobacteriophage LordLeafolot
Cagle, J., Kral, M., Carrington, L., Catoni, R., Cohn, O., Hellenbrand, H., Trayhan, J., Anderson, A., Bailey, L., Bloomer, E., et al. (2025) · PubMed Central · doi:10.17912/micropub.biology.001992
Rhaim, Z. (2025) · scholarworks - UTEP (The University of Texas at El Paso)
Zheng, W., Liang, Y., & Li, J. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1770578
Bacteriophages: A Long-forgotten Past, or Hope for the Future?
Agrawal, U. (2026) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25167
Phage therapy: Current advancements and future prospects in combating antimicrobial resistance
Wu, N., Zhu, T., & Cheng, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00010-2
Kalapala, Y. C., Ammembal, A. K., Jain, S., Barge, N. S., & Agarwal, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.714066
Yusuf, B., Ju, Y., Zhou, B., Malik, A., Alam, M. S., Li, L., Tadesse, H. A., Mulu, B. A., Fang, C., Tian, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.26.714485
Wang, Y., Li, H., Xue, B.-N., Zhao, X.-X., Rao, Y., Zhao, S., Fortuna, K. J., Ye, M., & Su, J. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141936
Kolenda, C. (2023) · theses.fr (ABES) · doi:10.70675/b2db5191z8a7ez4bd2z8725z58cdec54bd73
Cheng, J. (2026) · Hepatology Research · doi:10.1111/hepr.70184
Urdiales, O. A. A., & López, D. E. D. (2026) · Universidad Politécnica Salesiana Repositorio Digital (Universidad Politécnica Salesiana)
T7 phage adaptation to two ribosome-binding antibiotics
Wilcox, J., Miller, C. R., Peters, T. L., & Bull, J. J. (2026) · Bacteriophage · doi:10.1016/j.phage.2026.100003
Challenges and Prospective Trends of Phage Therapy
Mao, C. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837072026-00339
Single Phage and Cocktail Therapy
Mao, C. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837072026-00105
Phage Therapy Beyond Static Pharmaceuticals: A Framework for Controlled Evolutionary Platforms
Iwano, H., Fujiki, J., & Nakamura, T. (2026) · Viruses · doi:10.3390/v18050534
Efficacy and Safety Outcomes of Bacteriophage Therapy for Resistant Bacterial Infections
Cho, L., Chang, H., Cho, E., & Rajagopal, T. (2026) · Cureus · doi:10.7759/cureus.108749
Rehman, R. H. A., Durr-E-Najaf, Islam, A. W., Ahmed, S. I., Abdelaziz, K. M. S., Fodkar, A. S., Awan, M. S., & Zia, M. A. (2026) · Exploration of Drug Science · doi:10.37349/eds.2026.1008159
Idir, J. A., Drubi, F., Rodríguez, M., Cantallops, I., Domingo‐Calap, P., & Sardanyés, J. (2026) · Nonlinear Dynamics · doi:10.1007/s11071-026-12614-5
Sachan, R., Bhargava, K., Singh, A., Kumar, B., Shukla, A. D., Jeyekumar, E., & Lawrence, R. (2026) · International Journal of Advanced Research · doi:10.21474/ijar01/23450
Zhang, L., Zhang, Y., Shi, Y., Wang, F., Chen, M., Lv, J., Duan, Y., Li, X., Hu, L., He, Z., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10471-x
Abed, S., Sholeh, M., Sadeghi, S., Khatami, A., Speck, P. G., & Shafiei, M. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01050-3
Self-citationPharmacology of Bacteriophage Therapy in Children: A Re-Emerging Paradigm in Antibacterial Therapy
Le, J., Bradley, J. S., & Ramchandar, N. (2026) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/jppt-25-00151
Advances in mycobacteriophage research: from lytic mechanisms to one health applications
Han, R., Shen, L., Chen, V., Tan, X., An, N., 柯东晖, Li, Y., & Zeng, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1856292
Analysis of a Novel Cluster V Mycobacteriophage EniyanLRS and its Therapeutically Relevant LysBPreprint
Nadar, K., Eniyan, K., & Bajpai, U. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.26.734815
Bacteriophage therapy in musculoskeletal infections: a systematic review
Eschweiler, J., Migliorini, F., Schäfer, L., Fischer, C., Kobbe, P., Hofmann, U. K., & Langwald, S. (2026) · European journal of medical research · doi:10.1186/s40001-026-04808-9
Lewis, J. M., Dutton, O., Mistry, T., & Sagona, A. P. (2026) · PHAGE · doi:10.1177/26416549261465080
Yusuf, B., Malik, A., Alam, M. S., Li, L., Tadesse, H. A., Belachew, A. M., Fang, C., Tian, X., Aung, H. L., Wang, S. K., et al. (2026) · Journal of the Royal Society of New Zealand · doi:10.1002/snz2.70064
Bacteriophage Therapy of Mycobacterium abscessus Mastoiditis
Becken, B., Lauer, M. J., Russell, D. A., Garlena, R. A., Cristinziano, M., Abad, L., Dedrick, R. M., Jacobs‐Sera, D., Driscoll, C. L. W., Zwiener, J., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag439
Self-citationData mining reveals the diversity of prophage endolysins targeting pathogenic enterococci
O’Dea, F., Kinsella, A., Rady, B. J., Millard, A. D., Brown, J., Stafford, G. P., & Mesnage, S. (2026) · Journal of General Virology · doi:10.1099/jgv.0.002292
Targeting nontuberculous mycobacteria with phages: optimization of in vitro host range assays
Weirauch, T., Brügger, E., Litzius, K., Vehreschild, M. J. G. T., Würstle, S. M., & Lieberknecht-Jouy, S. C. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05452-3
Harnessing phages in the age of antibiotic resistance: immunological perspectives
Ahmad, T. A. A., Kabbara, D., Shokor, Z., & Saba, E. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1866625
Bonacorsi, A., Fusco, A., Manessi, D., Filippini, F., Casu, E., Marchetti, M., Palucci, I., Sali, M., Lai, M., Freer, G., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1823245
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies
Silva, T., Aiello, A., Alonzi, T., Carvalho, M. A., Finger, V., Goletti, D., Hoffner, S., Kherabi, Y., Korábečný, J., Kulczyńska, J., et al. (2026) · Medicinal Research Reviews · doi:10.1002/med.70096
Modeling Nontuberculous Mycobacterial Disease in Xenopus laevis
Peres, S., Pavelka, M. S., & Robert, J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33040080
The Therapeutic Potential of Phages in Multi-Drug Resistance Infections and Future Directions
Zhang, S., Tao, H., Zhao, S., & Wei, Y. (2026) · Viruses · doi:10.3390/v18090937
Xiong, L., Shen, X., Xiang, Y., Sun, J., Wang, T., Zhou, Q., Xiong, K., Wang, W., Geng, J., & Ji, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1921205
Novel lipid-associated loci determine phage-host interaction in Mycobacterium abscessus
Bernabéu-Gimeno, M., Kremer, L., & Domingo‐Calap, P. (2026) · npj Antimicrobials and Resistance · doi:10.1038/s44259-026-00269-6
Genome Sequence of Mycobacteriophage Lilbit
Clavette, E., Chuva, A., Gruener, N., Zinck, J., & Gusky, S. B. (2025) · PubMed Central · doi:10.17912/micropub.biology.001875
Flint, R. (2026) · UWA Profiles and Research Repository (UWA) · doi:10.26182/3ftt-7246
Lauer, M. J., Freeman, K. G., Jiang, D., Maneekul, J., VanDemark, A. P., & Hatfull, G. F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.16.752054
Self-citationBacteriophages in the Age of Antibiotic Resistance: Therapeutic and Industrial Applications
Tepeli, S. Ö., & Selvi, K. (2026) · Aksaray University Journal of Science and Engineering · doi:10.29002/asujse.1960299
Zaychikova, M. V., Malakhova, M. V., Kuznetsova, S., Bespiatykh, D., Kiselev, S., Klimina, K. M., Strokach, A. A., German, A., Lebedeva, A., Fursov, M. V., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198476
Avdeev, V. V., Александрович, В. М., Eliseev, P., Samoilova, A., Nikitina, N. A., Tyulkova, T. E., & Vasilyeva, I. A. (2026) · Microorganisms · doi:10.3390/microorganisms14102154
Alfadhli, A., Sritharan, S., Rangrej, D., Weitz, J. I., Hosseinidoust, Z., & Didar, T. F. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00563
Janssen, S., Fusco, A., Morrow, C. D., Guerrero-Bustamante, C. A., Freeman, K. G., van Ingen, J., van Wijk, R. C., Larsen, S. E., Coler, R. N., Hatfull, G. F., et al. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7536050
Self-citationRasuli, M. L. A., Pulungan, E. S., & Nurrizki, A. (2026) · Journal of Innovative and Creativity (Joecy) · doi:10.31004/joecy.v6i1.8473
The porin MspA is a phage-specific determinant of mycobacteriophage infectionPreprint
Kim, D., Maziero, M., Eckartt, K. A., DeJesus, M. A., Prensa, G. I., Navarro, A. G., Parker, D., Santucci, P., Rock, J. M., & Fossati, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.08.757660
The phage-host interaction landscape of Mycobacterium smegmatisPreprint
Maucourt, F., Lewis, C., Kazakov, A. E., Murray, I., Jacobs‐Sera, D., Deutschbauer, A. M., Wetzel, K. S., Niederweis, M., Hatfull, G. F., & Mutalik, V. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.09.757826
Self-citation
Metadata
- Authors
- Dedrick, R. M., Smith, B. E., Cristinziano, M., Freeman, K. G., Jacobs-Sera, D., Belessis, Y., Whitney Brown, A., Cohen, K. A., Davidson, R. M., van Duin, D., Gainey, A., Garcia, C. B., Robert George, C. R., Haidar, G., Ip, W., Iredell, J., Khatami, A., Little, J. S., Malmivaara, K., McMullan, B. J., Michalik, D. E., Moscatelli, A., Nick, J. A., Tupayachi Ortiz, M. G., Polenakovik, H. M., Robinson, P. D., Skurnik, M., Solomon, D. A., Soothill, J., Spencer, H., Wark, P., Worth, A., Schooley, R. T., Benson, C. A., & Hatfull, G. F.
- Affiliations
- University of Pittsburgh (US)
- Department of Biological Sciences, University of Pittsburgh , Pittsburgh, Pennsylvania , USA
- UNSW Sydney (AU)
- Inova Fairfax Hospital , Falls Church, Virginia , USA
- Johns Hopkins University (US)
- National Jewish Health (US)
- Division of Infectious Diseases, University of North Carolina , Chapel Hill, North Carolina , USA
- Prisma Health (US)
- Department of Respiratory Disease, Hospital Universitari Vall d’Hebron , Barcelona , Spain
- New South Wales Health Pathology Microbiology, John Hunter Hospital , New Lambton, New South Wales , Australia
- Great Ormond Street Hospital (GB)
- Sydney Children's Hospital (AU)
- Children's Hospital at Westmead (AU)
- Brigham and Women's Hospital (US)
- Miller Children's & Women's Hospital (US)
- Istituto Giannina Gaslini (IT)
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Miller School of Medicine, University of Miami , Miami, Florida , USA
- Wright State University (US)
- University of Helsinki (FI)
- Hunter Medical Research Institute (AU)
- University of California San Diego (US)
- Corresponding author
- Hatfull, Graham F
- ORCID
- Dedrick, Rebekah M
- Smith, Bailey E
- Freeman, Krista G
- Belessis, Yvonne
- Cohen, Keira A
- Davidson, Rebecca M
- Gainey, Andrew
- Haidar, Ghady
- Ip, Winnie
- Iredell, Jonathan
- Khatami, Ameneh
- Little, Jessica S
- McMullan, Brendan J
- Michalik, David E
- Moscatelli, Andrea
- Nick, Jerry A
- Polenakovik, Hari M
- Robinson, Paul D
- Skurnik, Mikael
- Solomon, Daniel A
- Spencer, Helen
- Wark, Peter
- Worth, Austen
- Schooley, Robert T
- Benson, Constance A
- Hatfull, Graham F
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-06-09
- Volume
- 76
- Issue
- 1
- Pages
- 103-112
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC9825826
- OpenAlex
- W4281760779
- Cited by
- 344
- References
- 23
- Citations by year
- 2026: 74 · 2025: 89 · 2024: 91 · 2023: 72 · 2022: 18
- FWCI
- 35.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Howard Hughes Medical Institute (GT12053)
- Cystic Fibrosis Foundation (HATFUL19GO, NICK20Y2-SVC, NICK20Y2-OUT)
- National Heart, Lung, and Blood Institute (K08 HL139994-01)
- Burroughs Wellcome Fund (HL146228, NICK20Y2-SVC and NICK20Y2-OUT)
- NIH (GM131729, AI154546, R01HL146228)
- Jane and Aatos Erkko Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- phage therapy, Mycobacterium abscessus, nontuberculous mycobacterial infection, cystic fibrosis, phage resistance, neutralizing antibodies, phage neutralization, compassionate use, adjunctive therapy
- MeSH terms
- Phage Therapy, Anti-Bacterial Agents, Bacteriophages, Cystic Fibrosis, Pharmaceutical Preparations, Humans, Mycobacterium, Mycobacterium Infections, Nontuberculous, Compassionate Use Trials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.